A Belfast woman who spent months in hospital after a seizure believes she is alive today thanks to her speedy diagnosis of a ...

GRIN Therapeutics & Angelini Pharma ink exclusive collaboration to develop and commercialize radiprodil outside North America: New York Wednesday, May 28, 2025, 15:00 Hrs [IST] GR ...

GRIN Therapeutics Inc. and Angelini Pharma have partnered for the development and commercial rights outside of North America ...

Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...

Burden of Memory Disorders and the Role of Traditional MedicineThe growing global population of elderly individuals has led to a dramatic rise in ...

A Cleveland Clinic psychiatrist explains how ketamine therapy is transforming depression treatment—and why it works when ...

This effect occurs, reports a new paper, because ATP-dependent vesicular release of astrocytic glutamate acts on presynaptic neuronal NMDA receptors to increase synaptic efficacy. You have full ...

Syndeio Biosciences today announced its launch to pioneer precision neurotherapeutics focused on repairing and enhancing synaptic function in central nervous system (CNS) diseases. The company's ...

Fig 1. CONSORT diagram (patient disposition). HER3, human epidermal growth factor receptor 3; PD, progressive disease. Fig 2. Kaplan-Meier plots of (A) PFS and (B) DOR, both by BICR per RECIST 1.1.